CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,355,000 | +54.0% | 247,200 | +6.6% | 0.16% | +39.8% |
| Q1 2021 | $5,426,000 | -19.1% | 232,000 | -0.3% | 0.12% | -16.9% |
| Q4 2020 | $6,703,000 | -35.8% | 232,743 | -54.9% | 0.14% | -46.4% |
| Q3 2020 | $10,448,000 | -32.6% | 515,680 | 0.0% | 0.26% | -37.6% |
| Q2 2020 | $15,496,000 | +111.1% | 515,680 | +120.8% | 0.42% | +40.3% |
| Q1 2020 | $7,339,000 | -33.3% | 233,500 | 0.0% | 0.30% | -12.9% |
| Q4 2019 | $11,000,000 | – | 233,500 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |